Medication Risk Management

Selected news for the healthcare topic - Medication Risk Management, collected since 11/2017. Recent stories appear in docwirenews.com and gurufocus.com. This healthcare topic shares news with Tabula Rasa HealthCare, Calvin H. Knowlton, DoseMe and many others.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics
Companies
People

Selected Headlines

Date Headline (link) Source Relevant Snippet
2/25/2021 Policy and vision for community pharmacies in Finland: A roadmap towards enhanced integration and reduced costs docwirenews.com ... a national steering group consisting of professional bodies, authorities, pharmacy schools and continuing education centers. The primary focus has been in patient counseling services and public health programs. The services have extended towards prospective medication risk management applying evidence-based tools, databases and digitalization. Research has been essential in informing progress by indicating high-risk patients, medications, practices and processes needing improvement. Despite the commitment of the profession and pharmacy ...
1/11/2021 Tabula Rasa HealthCare and Innovative Integrated Health Community Plans, Inc. Collaborate to Build Medicare Advantage Program gurufocus.com ... including pharmacy benefit services, in support of IIHCP's Medicare Advantage (MA) program. IIHCP provides healthcare services as a Medicare Advantage Plan.TRHC provides MA clients with a tailored approach to pharmacy benefit services, including medication risk management . 6 Warning Signs with NAS:TRHC. NAS:TRHC NAS:TRHC NAS:TRHC TRHC will provide Provider Network development assistance for IIHCP in the California counties of Fresno , Kern and Tulare . Services will be ...
9/9/2020 TRHC Announces Three Key Executive Hires Benzinga ... significantly expanded our market and end-user reach, it is important for us to continue to assemble an experienced and accomplished leadership team that will develop the next technology-enabled products and services for medication risk management and organizational performance optimization," said TRHC President and Chief Marketing and New Business Development Officer Orsula V. Knowlton, PharmD. "We welcome these new executives who will help TRHC deliver on our ambitious future ...
9/9/2020 TRHC Announces Three Key Executive Hires Globe Newswire ... significantly expanded our market and end-user reach, it is important for us to continue to assemble an experienced and accomplished leadership team that will develop the next technology-enabled products and services for medication risk management and organizational performance optimization,” said TRHC President and Chief Marketing and New Business Development Officer Orsula V. Knowlton, PharmD. “We welcome these new executives who will help TRHC deliver on our ambitious future ...
9/9/2020 TRHC Announces Three Key Executive Hires tabularasahealthcare.com ... significantly expanded our market and end-user reach, it is important for us to continue to assemble an experienced and accomplished leadership team that will develop the next technology-enabled products and services for medication risk management and organizational performance optimization,” said TRHC President and Chief Marketing and New Business Development Officer Orsula V. Knowlton, PharmD. “We welcome these new executives who will help TRHC deliver on our ambitious future ...
9/9/2020 TRHC Announces Three Key Executive Hires gurufocus.com ... significantly expanded our market and end-user reach, it is important for us to continue to assemble an experienced and accomplished leadership team that will develop the next technology-enabled products and services for medication risk management and organizational performance optimization,” said TRHC President and Chief Marketing and New Business Development Officer Orsula V. Knowlton, PharmD. “We welcome these new executives who will help TRHC deliver on our ambitious future ...
8/12/2020 Healthcare Times healthcaretimes.com ... in precision medicine to reduce healthcare costs and empower a healthier world. With scientific expertise that spans six decades, CLS bridges the gap between genetic knowledge and clinical application and offers the most comprehensive medication risk management program on the market. Visit coriell.com, email [email protected] or follow @CoriellLife. GENE THERAPY PROGRAM AT PENN MEDICINE JOINS AAVCOVID VACCINE PROJECT Renowned program led by James M. Wilson, MD, PhD, a leading ...
2/28/2020 Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2019 Results tabularasahealthcare.com ... 61% to $147.6 million, driven by contributions from acquisitions throughout 2018 and the first quarter of 2019 ($40.3 million) and 17% organic growth within our service offerings, led by continued strong growth from our medication risk management clinical programs. “I’m pleased to report a solid end to our 2019 fiscal year, a year in which we generated 20% organic growth, aggressively invested in sales personnel in order to advance future ...
2/27/2020 Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2019 Results Globe Newswire ... 61% to $147.6 million, driven by contributions from acquisitions throughout 2018 and the first quarter of 2019 ($40.3 million) and 17% organic growth within our service offerings, led by continued strong growth from our medication risk management clinical programs. “I’m pleased to report a solid end to our 2019 fiscal year, a year in which we generated 20% organic growth, aggressively invested in sales personnel in order to advance future ...
2/27/2020 Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2019 Results BioSpace ... 61% to $147.6 million, driven by contributions from acquisitions throughout 2018 and the first quarter of 2019 ($40.3 million) and 17% organic growth within our service offerings, led by continued strong growth from our medication risk management clinical programs. “I’m pleased to report a solid end to our 2019 fiscal year, a year in which we generated 20% organic growth, aggressively invested in sales personnel in order to advance future ...
11/9/2019 Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q3 2019 Results - Earnings Call Transcript Seeking Alpha ... PACE Association Annual Meeting was held October 13th through the 16th in New Orleans. As Cal mentioned, TRHC’s PACE companies are now united under our CareVention HealthCare PACE brand. The combined solution includes TRHC’s medication risk management , electronic health record, third-party administration, Medicare risk adjustment, and PACE consulting. In addition to multiple new business and client meetings, our annual PACE Appreciation Event attracted over 200 attendees. An Association update ...
11/5/2019 Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences Globe Newswire ... Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize performance to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications, including EireneRx® and MedWise™, provide solutions for a range of payers, providers and other healthcare organizations. For more information please visit, www.TRHC.com . Contact ...
9/23/2019 Tabula Rasa HealthCare’s CareKinesis® PACE Medication Risk Management Company and Pharmacy Convenes PACE Clinical Advisory Panel tabularasahealthcare.com s CareKinesis® PACE Medication Risk Management Company and Pharmacy Convenes PACE Clinical Advisory Panel Moorestown, NJ (September 23, 2019) – CareKinesis ®, a subsidiary of (NASDAQ:TRHC), hosted its 13th Clinical Advisory Panel (CAP) meeting September 19-20, 2019 in Lake Nona, Orlando, Florida. The annual meeting brought together Program of All-Inclusive Care for the Elderly (PACE) medical directors from across the country. The CareKinesis meeting is a highly anticipated training and ...
8/8/2019 Tabula Rasa HealthCare Announces Second Quarter 2019 Operating Results Globe Newswire ... recent acquisitions on track, and a robust pipeline of opportunities ahead of us. We demonstrated strong Year Two Enhanced Medication Therapy Management results and we began the process to integrate community pharmacists into our medication risk management process. We look forward to expanding this model and using the PrescribeWellness network with more of our customers,” said Calvin H. Knowlton, PhD, TRHC’s Chairman and Chief Executive Officer. Dr. Knowlton continued, “ The ...
5/12/2019 Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q1 Seeking Alpha ... this API integration model, our MedWise risk score provides adverse drug event risk alerts in workflow. The certified MedWise pharmacist employed by the practice or by Tabula Rasa is a major component of the medication risk management process, both for the individual consumer and for the risk population. Third, our PrescribeWellness network of eventually certified MedWise community pharmacists will be able to both initiate and monitor changes, along with educating ...
5/8/2019 Tabula Rasa HealthCare Announces First Quarter 2019 Operating Results Globe Newswire ... our services rapidly in markets beyond PACE and believe that as the industry transitions from focusing on service to focusing on outcomes Tabula Rasa is well positioned to become the go-to provider for medication risk management .” Financial Performance for the Three Months Ended March 31, 2019 All comparisons, unless otherwise noted, are to the three months ended March 31, 2018. Total revenue was $61.0 million, an increase of 39 ...
11/7/2017 Tabula Rasa HealthCare's (TRHC) CEO Calvin Knowlton on Q3 2017 Results - Earnings Call Transcript Seeking Alpha ... a 38% increase year-over-year. Product in the quarter was $24.6 million, compared to $20.7 million in the same period a year ago. As a reminder, product revenue is primarily generated through our medication risk management contracts in the PACE market and the growth this quarter was mainly the result of expansion within our current client base. Service revenue driven by our non-PACE medication risk management contracts which ...